| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.00042 | 1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.00048 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.00028 | 1 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.00021 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 7.1e-05 | 1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -8.2e-06 | 1 |